Molecular genetics of tetrahydrobiopterin‐responsive phenylalanine hydroxylase deficiency

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Human Mutation

• Publication date

  2008-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/HUMU.20637PMID 17935162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of tetrahydrobiopterin responsiveness in Turkish hyperphenylalaninemic patients.

  2007cited by this paper
• BH4 responsiveness associated to a PKU mutation with decreased binding affinity for the cofactor.

  2007cited by this paper
• Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria.

  2007influential reference
• The spectrum of phenylalanine variations under tetrahydrobiopterin load in subjects affected by phenylalanine hydroxylase deficiency

  2006cited by this paper
• Analysis of the effect of tetrahydrobiopterin on PAH gene expression in hepatoma cells

  2006influential reference
• Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study.

  2005cited by this paper
• Long-term treatment of patients with mild and classical phenylketonuria by tetrahydrobiopterin.

  2005cited by this paper
• Kinetic and stability analysis of PKU mutations identified in BH4-responsive patients.

  2005cited by this paper
• Phenylketonuria mutations in Northern China.

  2005cited by this paper
• Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria.

  2005cited by this paper
• Incidence of BH4-responsiveness in phenylalanine-hydroxylase-deficient Italian patients.

  2005cited by this paper
• Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin.

  2005cited by this paper
• Stimulation of hepatic phenylalanine hydroxylase activity but not Pah-mRNA expression upon oral loading of tetrahydrobiopterin in normal mice.

  2005cited by this paper
• Tetrahydrobiopterin-responsive phenylketonuria: the New South Wales experience.

  2005cited by this paper
• Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy.

  2005cited by this paper
• Response of patients with phenylketonuria in the US to tetrahydrobiopterin.

  2005cited by this paper
• The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.

  2004influential reference
• Long-term follow-up of a patient with mild tetrahydrobiopterin-responsive phenylketonuria.

  2004cited by this paper
• Tetrahydrobiopterin responsiveness in patients with phenylketonuria.

  2004cited by this paper
• Wild-type phenylalanine hydroxylase activity is enhanced by tetrahydrobiopterin supplementation in vivo: an implication for therapeutic basis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.

  2004cited by this paper
• Long-Term Treatment and Diagnosis of Tetrahydrobiopterin-Responsive Hyperphenylalaninemia with a Mutant Phenylalanine Hydroxylase Gene

  2004influential reference
• Efficiency of long-term tetrahydrobiopterin monotherapy in phenylketonuria

  2004cited by this paper
• Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: Implications for tetrahydrobiopterin‐responsive hyperphenylalaninemia

  2004influential reference
• The molecular basis of phenylketonuria in Koreans

  2004cited by this paper
• Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations

  2004influential reference
• Tetrahydrobiopterin responsiveness: results of the BH4 loading test in 31 Spanish PKU patients and correlation with their genotype.

  2004cited by this paper
• Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations.

  2004cited by this paper
• PAHdb 2003: What a locus‐specific knowledgebase can do

  2003cited by this paper
• Structural studies on phenylalanine hydroxylase and implications toward understanding and treating phenylketonuria.

  2003cited by this paper
• A hypothesis on the biochemical mechanism of BH4-responsiveness in phenylalanine hydroxylase deficiency

  2003cited by this paper
• Phenylketonuria mutations in Europe

  2003influential reference
• High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1,919 patients observed from 1988 to 2002.

  2002cited by this paper
• Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.

  2002cited by this paper
• The hyperphenylalaninemia : phenylalanine hydroxylase deficiency

  2001influential reference
• Successful treatment of phenylketonuria with tetrahydrobiopterin

  2001cited by this paper
• A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria

  2001cited by this paper
• The V388M mutation results in a kinetic variant form of phenylalanine hydroxylase.

  2000cited by this paper
• Structural interpretation of mutations in phenylalanine hydroxylase protein aids in identifying genotype–phenotype correlations in phenylketonuria

  2000cited by this paper
• Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.

  1999cited by this paper
• Phenylketonuria mutations in Germany

  1999cited by this paper
• In vitro expression analysis of mutations in phenylalanine hydroxylase: Linking genotype to phenotype and structure to function

  1998cited by this paper
• A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype.

  1998cited by this paper
• Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations.

  1997cited by this paper
• Phenylketonuria mutation analysis in Northern Ireland: a rapid stepwise approach.

  1995cited by this paper

• The clinical utility of short-term protein substitute use during intercurrent illness in BH4-responsive phenylketonuria.

  2025cites this paper
• Current state of the treatment landscape of phenylketonuria

  2025cites this paper
• Diagnosing late-onset PKU in the shadow of refractory seizures

  2025cites this paper
• Development of ınnovative products for phenylketonuria (PKU) patients: Muffin dessert

  2025cites this paper
• Sapropterin Dihydrochloride Responsiveness in Phenylketonuria: A Case Series Exploring Gaps in Comprehensive Patient Monitoring

  2025cites this paper
• Genomic profiling, implications for genotype-based treatment of 131 patients with phenylketonuria and characterization of novel p.Pro416Leu PAH variant

  2025influential citation
• Genetic Landscape and Clinical Features of Hyperphenylalaninemia in North Ossetia-Alania: High Frequency of P281L and P211T Genetic Variants in the PAH Gene

  2024cites this paper
• Maximal dietary responsiveness after tetrahydrobiopterin (BH4) in 19 phenylalanine hydroxylase deficiency patients: What super-responders can expect

  2024cites this paper
• Factors Impacting the Reduction in Neophobia Prevalence in Phenylketonuria Patients

  2024cites this paper
• IN SILICO APPROACHES ON PHENYLALANINE HYDROXYLASE INHIBITOR-RELATED COMPOUNDS USED IN PARKINSON’S DISEASE TREATMENT

  2024influential citation
• Triple Genetic Diagnosis in a Patient with Late-Onset Leukodystrophy and Mild Intellectual Disability

  2023cites this paper
• Neurotransmitters Disorders with Mild Hyperphenylalaninemia: The Ones That Should Not Be Missed.

  2023cites this paper
• State‐of‐the‐art 2023 on gene therapy for phenylketonuria

  2023cites this paper
• Relationship satisfaction in adults with phenylketonuria is positively associated with following recommended treatment, having a partner involved in management, and maintaining good health

  2023cites this paper
• Detection of Single-Nucleotide and Copy Number Defects Underlying Hyperphenylalaninemia by Next-Generation Sequencing

  2023cites this paper
• Recent Advances in Phenylketonuria: A Review

  2023cites this paper
• Protein substitutions as new-generation pharmanutrition approach to managing phenylketonuria

  2022cites this paper
• Mutation spectrum of PTS gene in patients with tetrahydrobiopterin deficiency from jiangxi province

  2022cites this paper
• Tetrahydrobiopterin responsiveness in Phenylalanine hydroxylase deficient patients from North-east of Iran: Genotype-phenotype correlation, identification of a novel mutation and 7 new responsive genotypes.

  2022cites this paper
• Importance of the long non-coding RNA (lncRNA) transcript HULC for the regulation of phenylalanine hydroxylase and treatment of phenylketonuria.

  2022cites this paper
• [A long non-coding RNA regulates the activity of phenylalanine hydroxylase, the key enzyme of phenylketonuria].

  2022cites this paper
• A capillary electrophoresis-based variant hotspot genotyping method for rapid and reliable analysis of the phenylalanine hydroxylase gene in the Chinese Han population.

  2021cites this paper
• Amino acid metabolism disorders and PAH gene mutations in Southeastern Anatolia Region

  2021cites this paper
• Analysis of the PAH Gene Mutations in the Ukrainian Population: A Report from the West Ukrainian Region

  2021cites this paper
• BH4-deficient hyperphenylalaninemia in Russia

  2021cites this paper
• Identifying and elucidating the roles of Y198N and Y204F mutations in the PAH enzyme through molecular dynamic simulations

  2021cites this paper
• Italian national consensus statement on management and pharmacological treatment of phenylketonuria

  2021cites this paper
• Tetrahydrobiopterin in phenylketonuria: Who can benefit?

  2020cites this paper
• Lipids and phenylketonuria: Current evidences pointed the need for lipidomics studies.

  2020cites this paper
• Inherited Metabolic Disorders: A Current Status

  2020cites this paper
• [Phenylketonuria, from diet to gene therapy].

  2020cites this paper
• The Phenyl Ketonuria ( PKU ) and Teratogenic Risks ( Congenital Defects )

  2020cites this paper
• Spectrum of PAH gene mutations and genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Shanxi province.

  2020cites this paper
• A novel Pah-exon1 deleted murine model of phenylalanine hydroxylase (PAH) deficiency.

  2020cites this paper
• IDENTIFICATION OF MUTATIONS IN THE PAH GENE IN PKU PATIENTS IN THE STATE OF MATO GROSSO

  2020cites this paper
• Experiences with offering pro bono medical genetics services in the West Indies: Benefits to patients, physicians, and the community

  2020cites this paper
• Genotype‐phenotype correlations and BH4 estimated responsiveness in patients with phenylketonuria from Rio de Janeiro, Southeast Brazil

  2019influential citation
• Molecular-Genetic Study of Phenylketonuria in Patients from Georgia

  2019cites this paper
• Phenylalanine hydroxylase genotype-phenotype associations in the United States: A single center study.

  2019cites this paper
• Prospects for Cell-Directed Curative Therapy of Phenylketonuria (PKU)

  2019cites this paper
• Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia

  2019cites this paper
• The study of the full spectrum of variants leading to hyperphenylalaninemia have revealed 10 new variants in the PAH gene

  2019cites this paper
• Structural and Functional Impact of Seven Missense Variants of Phenylalanine Hydroxylase

  2019influential citation
• Charakterisierung eines Mausmodells zur BH4-sensitiven Phenylketonurie

  2019cites this paper
• International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria.

  2019cites this paper
• Allelic phenotype values: a model for genotype-based phenotype prediction in phenylketonuria

  2018cites this paper
• Mutational spectrum of the phenylalanine hydroxylase gene in patients with phenylketonuria in the central region of China

  2018cites this paper
• Molecular genetics of a cohort of 635 cases of phenylketonuria in a consanguineous population

  2018cites this paper
• Molecular-genetic causes for the high frequency of phenylketonuria in the population from the North Caucasus

  2018cites this paper
• Functional Characterization of Novel Phenylalanine Hydroxylase p.Gln226Lys Mutation Revealed Its Non-responsiveness to Tetrahydrobiopterin Treatment in Hepatoma Cellular Model

  2018cites this paper
• A Simple Network to Remove Interference in Surface EMG Signal from Single Gene Affected Phenylketonuria Patients for Proper Diagnosis

  2018cites this paper
• Secondary BH4 deficiency links protein homeostasis to regulation of phenylalanine metabolism

  2018cites this paper
• A Simple Network to Remove Interference in Surface EMG Signal from Single Gene Affected Phenylketonuria Patients for Proper Diagnosis

  2018cites this paper
• Understanding of the phenylketonuria problem through history

  2018cites this paper
• The spectrum of mutations in the PAH gene in patients with hyperphenylalaninemia from the Karachay-Cherkess Republic

  2017cites this paper
• The complete European guidelines on phenylketonuria: diagnosis and treatment

  2017cites this paper
• Phenylketonuria felnőttkorban

  2017cites this paper
• Potential role of amino acids in pathogenesis of schizophrenia

  2017cites this paper
• Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria

  2017cites this paper
• The Predictive Value of Genetic Analyses in the Diagnosis of Tetrahydrobiopterin (BH4)-Responsiveness in Chinese Phenylalanine Hydroxylase Deficiency Patients

  2017cites this paper
• Reassessing the significance of the PAH c.158G>A (p.Arg53His) variant in patients with hyperphenylalaninemia

  2017cites this paper
• [Adult phenylketonuria].

  2017cites this paper
• Phenylketonuria: A new look at an old topic, advances in laboratory diagnosis, and therapeutic strategies

  2017cites this paper
• Year : 2011 Diagnosis , classification , and genetics of phenylketonuria and tetrahydrobiopterin ( BH 4 ) deficiencies

  2017cites this paper
• The Effect of Large Neutral Amino Acids on Blood Phenylalanine Levels in Patients with Classical Phenylketonuria

  2017cites this paper
• Amino acids disorders

  2017cites this paper
• Genotyping of patients with phenylketonuria from different regions of Russia for determining BH4 responsiveness

  2017cites this paper
• Molecular epidemiology, genotype–phenotype correlation and BH4 responsiveness in Spanish patients with phenylketonuria

  2016cites this paper
• The Molecular Genetics of Autosomal Recessive Nonsyndromic Intellectual Disability: a Mutational Continuum and Future Recommendations

  2016cites this paper
• Phenylketonuria Treatment’s Impact on Physical Growth: A Spanish Retrospective Longitudinal Study

  2016cites this paper
• Co-expression of phenylalanine hydroxylase variants and effects of interallelic complementation on in vitro enzyme activity and genotype-phenotype correlation.

  2016cites this paper
• Mutation spectrum of the PAH gene in phenylketonuria patients in the Karachay-Cherkess Republic (Russia)

  2016cites this paper
• Genetics of Phenylketonuria: Then and Now

  2016cites this paper
• Molecular mechanisms of PAH function in response to phenylalanine and tetrahydrobiopterin binding

  2016influential citation
• Genotype-phenotype associations in French patients with phenylketonuria and importance of genotype for full assessment of tetrahydrobiopterin responsiveness

  2015influential citation
• Mutational spectrum of phenylketonuria in Jiangsu province

  2015cites this paper
• Dictyostelium discoideum Ax2 as an Assay System for Screening of Pharmacological Chaperones for Phenylketonuria Mutations.

  2015cites this paper
• Correlation between genotype and the tetrahydrobiopterin-responsive phenotype in Chinese patients with phenylketonuria

  2015cites this paper
• Development of an innovative strategy based on engineered autologous erythrocytes as “enzyme replacement therapy” for the treatment of Phenylketonuria

  2015cites this paper
• Phenylalanine hydroxylase deficiency in south Italy: Genotype-phenotype correlations, identification of a novel mutant PAH allele and prediction of BH4 responsiveness.

  2015cites this paper
• Phenylketonuria TreatmentsImpact on Physical Growth:A Spanish RetrospectiveLongitudinal Study

  2015cites this paper
• Minimally invasive (13)C-breath test to examine phenylalanine metabolism in children with phenylketonuria.

  2015cites this paper
• Application of stable isotope tracers to examine phenylalanine metabolism and protein requirements in children with phenylketonuria (pku)

  2015cites this paper
• Phenylketonuria Treatment's Impact on Physical Growth:

  2015cites this paper
• Mapping the functional landscape of frequent phenylalanine hydroxylase (PAH) genotypes promotes personalised medicine in phenylketonuria

  2015cites this paper
• Introduction to Genetics

  2015cites this paper
• Phenylalanine hydroxylase deficiency in Mexico: genotype–phenotype correlations, BH4 responsiveness and evidence of a founder effect

  2015cites this paper
• Linking genotypes database with locus-specific database and genotype–phenotype correlation in phenylketonuria

  2014cites this paper
• Use of sapropterin dihydrochloride in maternal phenylketonuria. A European experience of eight cases

  2014cites this paper
• Genetics of gastrointestinal atresias.

  2014cites this paper
• Molecular genetics and diagnosis of phenylketonuria: state of the art

  2014cites this paper
• Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators

  2014cites this paper
• Functional Characterization and Categorization of Missense Mutations that Cause Methylmalonyl‐CoA Mutase (MUT) Deficiency

  2014cites this paper
• Association of common variants in PAH and LAT1 with non-syndromic cleft lip with or without cleft palate (NSCL/P) in the Polish population.

  2014cites this paper
• Phenylketonuria: translating research into novel therapies.

  2014cites this paper
• Molecular Genetics and Gene Therapy Aspects of Phenylalanine Hydroxylase (PAH) Related Hyperphenylalaninemias

  2014cites this paper
• Phenylketonuria Scientific Review Conference: state of the science and future research needs.

  2014cites this paper
• Molecular genetics and diagnosis of phenylketonuria : state of the art Expert

  2014cites this paper
• Influence of PAH Genotype on Sapropterin Response in PKU: Results of a Single-Center Cohort Study.

  2014influential citation
• Genomics and Oral Health: An Overview

  2014cites this paper